Role of 5α-Reductase Inhibitors in Androgen-Stimulated Skin Disorders

    February 2013 in “ PubMed ”
    Faris Azzouni, Nathalie C. Zeitouni, James L. Mohler
    Studysummary This review discusses the pathophysiology of androgen-stimulated skin disorders and key clinical trials of 5α-reductase inhibitors for their treatment, but it does not report new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Related research 2

    1. Role of 5α-Reductase Inhibitors in Androgen-Stimulated Skin Disorders PubMed · 2013
    2. Finasteride: A New Drug for the Treatment of Male Hirsutism and Androgenetic Alopecia? PubMed · 1996